One of the major challenges facing healthcare companies is overcoming the complexity inherent in spinal health, exacerbated by the reduced healing capacity associated with an aging population who often present with multiple comorbidities, where these spinal conditions are most prevalent.

As scientific understanding of our biology deepens, it is increasingly apparent that not only do we need to address the internal machinery of cells, but also their complex microenvironments that provide signals via surface chemistry, soluble factors, local elasticity, cell-to-cell communication and architecture to regulate their action.

Locate’s platform technology (TAOS®) is designed to bring a combination approach to these complex conditions, offering a range of hard and soft tissue matrices which can deliver bioactives (stem cells, small molecules and biologics) at the intended site, for longer.